Baytril® (enrofloxacin) Antibacterial Injectable Solution 2.27%

Baytril® Injectable Solution 2.27% is a broad-spectrum fluoroquinolone indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. It has activity against both Gram-negative and Gram-positive bacteria, including those causing dermal, urinary and respiratory tract infections. Baytril® (enrofloxacin) Injectable Solution 2.27% is approved for use in dogs only.

Key benefits

  • Concentration-dependent and bactericidal
  • Kills a broad range of disease-causing bacteria, right at the site of infection
  • More than 20 years of performance
  • Anti-infectivesAnti-infectives
  • DermatologyDermatology


  • Bacterial infections
  • Dermatology
  • Infections
  • Respiratory Infection
  • Urinary Tract Infection

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal law prohibits the extra label use of this drug in food-producing animals.

WARNINGS: For use in animals only. The use of this product in cats may result in Retinal Toxicity. Keep out of reach of children.

CONTRAINDICATIONS: Enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones.

PRECAUTION: Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders.

Baytril® (enrofloxacin) Antibacterial Injectable Solution 2.27% FAQs

What are the packaging specifications for Baytril® (enrofloxacin) Antibacterial Injectable Solution 2.27%?

1Walker RD, et al. (1992). Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am J Res. 53(DEC):2315-2319.

Baytril is a registered trademark of Bayer.